nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0325	0.0446	CbGbCtD
Rimonabant—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0306	0.0419	CbGbCtD
Rimonabant—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0306	0.0419	CbGbCtD
Rimonabant—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0293	0.0402	CbGbCtD
Rimonabant—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0277	0.0379	CbGbCtD
Rimonabant—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0276	0.0378	CbGbCtD
Rimonabant—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0276	0.0378	CbGbCtD
Rimonabant—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0268	0.0367	CbGbCtD
Rimonabant—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0252	0.0345	CbGbCtD
Rimonabant—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0252	0.0345	CbGbCtD
Rimonabant—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0249	0.0342	CbGbCtD
Rimonabant—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0249	0.0342	CbGbCtD
Rimonabant—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0232	0.0318	CbGbCtD
Rimonabant—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0228	0.0312	CbGbCtD
Rimonabant—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0228	0.0312	CbGbCtD
Rimonabant—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0215	0.0295	CbGbCtD
Rimonabant—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.021	0.0287	CbGbCtD
Rimonabant—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0209	0.0286	CbGbCtD
Rimonabant—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0197	0.027	CbGbCtD
Rimonabant—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0191	0.0262	CbGbCtD
Rimonabant—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0189	0.0259	CbGbCtD
Rimonabant—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0189	0.0259	CbGbCtD
Rimonabant—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0181	0.0248	CbGbCtD
Rimonabant—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0173	0.0237	CbGbCtD
Rimonabant—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.0237	CbGbCtD
Rimonabant—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.017	0.0234	CbGbCtD
Rimonabant—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.016	0.022	CbGbCtD
Rimonabant—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.016	0.022	CbGbCtD
Rimonabant—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0145	0.0199	CbGbCtD
Rimonabant—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0145	0.0199	CbGbCtD
Rimonabant—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0125	0.0171	CbGbCtD
Rimonabant—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0121	0.0166	CbGbCtD
Rimonabant—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.011	0.0151	CbGbCtD
Rimonabant—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0151	CbGbCtD
Rimonabant—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0105	0.0144	CbGbCtD
Rimonabant—CNR2—lymphoid tissue—acquired immunodeficiency syndrome	0.00392	0.124	CbGeAlD
Rimonabant—CNR2—blood—acquired immunodeficiency syndrome	0.00369	0.117	CbGeAlD
Rimonabant—CNR2—nervous system—acquired immunodeficiency syndrome	0.00299	0.095	CbGeAlD
Rimonabant—CNR2—central nervous system—acquired immunodeficiency syndrome	0.00288	0.0915	CbGeAlD
Rimonabant—CNR2—brain—acquired immunodeficiency syndrome	0.00229	0.0726	CbGeAlD
Rimonabant—CNR1—lung—acquired immunodeficiency syndrome	0.00225	0.0714	CbGeAlD
Rimonabant—CNR1—brain—acquired immunodeficiency syndrome	0.00159	0.0505	CbGeAlD
Rimonabant—CNR1—lymph node—acquired immunodeficiency syndrome	0.00154	0.0488	CbGeAlD
Rimonabant—CNR1—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0015	0.0485	CbGpPWpGaD
Rimonabant—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0454	CbGeAlD
Rimonabant—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00136	0.0431	CbGeAlD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00117	0.038	CbGpPWpGaD
Rimonabant—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0328	CbGeAlD
Rimonabant—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0323	CbGeAlD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000919	0.0298	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000892	0.0289	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00071	0.023	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0007	0.0227	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000642	0.0208	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000557	0.018	CbGpPWpGaD
Rimonabant—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00055	0.0174	CbGeAlD
Rimonabant—CNR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00054	0.0175	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000539	0.0175	CbGpPWpGaD
Rimonabant—CYP1A2—blood—acquired immunodeficiency syndrome	0.000524	0.0166	CbGeAlD
Rimonabant—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000522	0.0166	CbGeAlD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000504	0.0163	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000499	0.0162	CbGpPWpGaD
Rimonabant—CYP2C9—blood—acquired immunodeficiency syndrome	0.000497	0.0158	CbGeAlD
Rimonabant—CNR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000489	0.0158	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000469	0.0152	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000469	0.0152	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000463	0.015	CbGpPWpGaD
Rimonabant—CYP1A2—lung—acquired immunodeficiency syndrome	0.000459	0.0146	CbGeAlD
Rimonabant—CNR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000458	0.0148	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000438	0.0142	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000435	0.0141	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000424	0.0137	CbGpPWpGaD
Rimonabant—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000398	0.0126	CbGeAlD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000396	0.0129	CbGpPWpGaD
Rimonabant—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000392	0.0124	CbGeAlD
Rimonabant—CNR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000391	0.0127	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000383	0.0124	CbGpPWpGaD
Rimonabant—CYP3A4—blood—acquired immunodeficiency syndrome	0.000379	0.012	CbGeAlD
Rimonabant—CYP2D6—blood—acquired immunodeficiency syndrome	0.000373	0.0118	CbGeAlD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000373	0.0121	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000373	0.0121	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000368	0.0119	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000368	0.0119	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000363	0.0118	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000359	0.0116	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000357	0.0116	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000344	0.0112	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000341	0.0111	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000334	0.0108	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000321	0.0104	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000311	0.0101	CbGpPWpGaD
Rimonabant—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000308	0.00977	CbGeAlD
Rimonabant—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00147	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.00147	CcSEcCtD
Rimonabant—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000305	0.00147	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00146	CcSEcCtD
Rimonabant—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00146	CcSEcCtD
Rimonabant—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00146	CcSEcCtD
Rimonabant—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00146	CcSEcCtD
Rimonabant—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000303	0.00961	CbGeAlD
Rimonabant—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00145	CcSEcCtD
Rimonabant—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00145	CcSEcCtD
Rimonabant—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000302	0.00145	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000302	0.00979	CbGpPWpGaD
Rimonabant—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.00144	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00144	CcSEcCtD
Rimonabant—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000299	0.00144	CcSEcCtD
Rimonabant—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000299	0.00144	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000298	0.00967	CbGpPWpGaD
Rimonabant—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00143	CcSEcCtD
Rimonabant—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000296	0.0094	CbGeAlD
Rimonabant—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00142	CcSEcCtD
Rimonabant—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00142	CcSEcCtD
Rimonabant—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.00142	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00142	CcSEcCtD
Rimonabant—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00141	CcSEcCtD
Rimonabant—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00141	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000292	0.00948	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000292	0.00948	CbGpPWpGaD
Rimonabant—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000292	0.0014	CcSEcCtD
Rimonabant—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.0014	CcSEcCtD
Rimonabant—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000292	0.00925	CbGeAlD
Rimonabant—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000291	0.0014	CcSEcCtD
Rimonabant—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.0014	CcSEcCtD
Rimonabant—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000291	0.0014	CcSEcCtD
Rimonabant—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000289	0.00139	CcSEcCtD
Rimonabant—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000289	0.00139	CcSEcCtD
Rimonabant—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000288	0.00139	CcSEcCtD
Rimonabant—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000287	0.00138	CcSEcCtD
Rimonabant—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00138	CcSEcCtD
Rimonabant—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00137	CcSEcCtD
Rimonabant—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00137	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000284	0.0092	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000284	0.0092	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000284	0.00919	CbGpPWpGaD
Rimonabant—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00136	CcSEcCtD
Rimonabant—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000283	0.00136	CcSEcCtD
Rimonabant—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00136	CcSEcCtD
Rimonabant—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00135	CcSEcCtD
Rimonabant—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000281	0.00135	CcSEcCtD
Rimonabant—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00135	CcSEcCtD
Rimonabant—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000281	0.00135	CcSEcCtD
Rimonabant—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00135	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00028	0.00907	CbGpPWpGaD
Rimonabant—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00028	0.00134	CcSEcCtD
Rimonabant—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00134	CcSEcCtD
Rimonabant—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000279	0.00134	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00134	CcSEcCtD
Rimonabant—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000279	0.00134	CcSEcCtD
Rimonabant—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000278	0.00134	CcSEcCtD
Rimonabant—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00133	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000277	0.00899	CbGpPWpGaD
Rimonabant—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000277	0.00133	CcSEcCtD
Rimonabant—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00133	CcSEcCtD
Rimonabant—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00132	CcSEcCtD
Rimonabant—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000275	0.00132	CcSEcCtD
Rimonabant—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00132	CcSEcCtD
Rimonabant—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000275	0.00132	CcSEcCtD
Rimonabant—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00131	CcSEcCtD
Rimonabant—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00131	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00027	0.00876	CbGpPWpGaD
Rimonabant—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.0013	CcSEcCtD
Rimonabant—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00129	CcSEcCtD
Rimonabant—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00129	CcSEcCtD
Rimonabant—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00128	CcSEcCtD
Rimonabant—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000265	0.00127	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00127	CcSEcCtD
Rimonabant—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00127	CcSEcCtD
Rimonabant—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00127	CcSEcCtD
Rimonabant—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00127	CcSEcCtD
Rimonabant—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00126	CcSEcCtD
Rimonabant—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00126	CcSEcCtD
Rimonabant—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000262	0.00126	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000262	0.00849	CbGpPWpGaD
Rimonabant—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00126	CcSEcCtD
Rimonabant—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.00125	CcSEcCtD
Rimonabant—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00125	CcSEcCtD
Rimonabant—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.00124	CcSEcCtD
Rimonabant—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00124	CcSEcCtD
Rimonabant—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000258	0.00124	CcSEcCtD
Rimonabant—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00124	CcSEcCtD
Rimonabant—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.00123	CcSEcCtD
Rimonabant—Rash—Didanosine—acquired immunodeficiency syndrome	0.000256	0.00123	CcSEcCtD
Rimonabant—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.00123	CcSEcCtD
Rimonabant—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00123	CcSEcCtD
Rimonabant—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000256	0.00123	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000255	0.00828	CbGpPWpGaD
Rimonabant—Headache—Didanosine—acquired immunodeficiency syndrome	0.000254	0.00122	CcSEcCtD
Rimonabant—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000254	0.00122	CcSEcCtD
Rimonabant—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000253	0.00122	CcSEcCtD
Rimonabant—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00122	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000252	0.00817	CbGpPWpGaD
Rimonabant—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00121	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000251	0.00813	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.0012	CcSEcCtD
Rimonabant—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.0012	CcSEcCtD
Rimonabant—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.0012	CcSEcCtD
Rimonabant—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00025	0.0012	CcSEcCtD
Rimonabant—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000249	0.0012	CcSEcCtD
Rimonabant—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000249	0.0012	CcSEcCtD
Rimonabant—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.0012	CcSEcCtD
Rimonabant—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000248	0.00119	CcSEcCtD
Rimonabant—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00119	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00119	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00118	CcSEcCtD
Rimonabant—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000246	0.00118	CcSEcCtD
Rimonabant—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00118	CcSEcCtD
Rimonabant—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00118	CcSEcCtD
Rimonabant—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00117	CcSEcCtD
Rimonabant—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00117	CcSEcCtD
Rimonabant—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00117	CcSEcCtD
Rimonabant—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.00116	CcSEcCtD
Rimonabant—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00116	CcSEcCtD
Rimonabant—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00116	CcSEcCtD
Rimonabant—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00116	CcSEcCtD
Rimonabant—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000241	0.00116	CcSEcCtD
Rimonabant—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00115	CcSEcCtD
Rimonabant—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00114	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00114	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000237	0.00768	CbGpPWpGaD
Rimonabant—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00113	CcSEcCtD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000234	0.00758	CbGpPWpGaD
Rimonabant—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00112	CcSEcCtD
Rimonabant—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000234	0.00112	CcSEcCtD
Rimonabant—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00112	CcSEcCtD
Rimonabant—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00112	CcSEcCtD
Rimonabant—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00112	CcSEcCtD
Rimonabant—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.00112	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Rimonabant—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Rimonabant—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Rimonabant—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Rimonabant—CYP2D6—brain—acquired immunodeficiency syndrome	0.000232	0.00735	CbGeAlD
Rimonabant—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00111	CcSEcCtD
Rimonabant—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00111	CcSEcCtD
Rimonabant—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00111	CcSEcCtD
Rimonabant—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.00111	CcSEcCtD
Rimonabant—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.00111	CcSEcCtD
Rimonabant—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00023	0.0011	CcSEcCtD
Rimonabant—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000229	0.0011	CcSEcCtD
Rimonabant—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.0011	CcSEcCtD
Rimonabant—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00109	CcSEcCtD
Rimonabant—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00109	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00109	CcSEcCtD
Rimonabant—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000225	0.00108	CcSEcCtD
Rimonabant—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00108	CcSEcCtD
Rimonabant—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000225	0.00108	CcSEcCtD
Rimonabant—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000224	0.00108	CcSEcCtD
Rimonabant—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.00108	CcSEcCtD
Rimonabant—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00107	CcSEcCtD
Rimonabant—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00107	CcSEcCtD
Rimonabant—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00107	CcSEcCtD
Rimonabant—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00107	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000223	0.00722	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000223	0.00722	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000223	0.00721	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Rash—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Rimonabant—Headache—Stavudine—acquired immunodeficiency syndrome	0.000221	0.00106	CcSEcCtD
Rimonabant—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000221	0.00106	CcSEcCtD
Rimonabant—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00106	CcSEcCtD
Rimonabant—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00022	0.00106	CcSEcCtD
Rimonabant—Rash—Abacavir—acquired immunodeficiency syndrome	0.000219	0.00105	CcSEcCtD
Rimonabant—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000219	0.00105	CcSEcCtD
Rimonabant—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00105	CcSEcCtD
Rimonabant—Headache—Abacavir—acquired immunodeficiency syndrome	0.000218	0.00105	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000218	0.00705	CbGpPWpGaD
Rimonabant—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00104	CcSEcCtD
Rimonabant—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.00104	CcSEcCtD
Rimonabant—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00104	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000216	0.007	CbGpPWpGaD
Rimonabant—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00104	CcSEcCtD
Rimonabant—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00103	CcSEcCtD
Rimonabant—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00103	CcSEcCtD
Rimonabant—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.00102	CcSEcCtD
Rimonabant—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00102	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000212	0.00688	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00102	CcSEcCtD
Rimonabant—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00101	CcSEcCtD
Rimonabant—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.00101	CcSEcCtD
Rimonabant—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00101	CcSEcCtD
Rimonabant—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000209	0.00101	CcSEcCtD
Rimonabant—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.001	CcSEcCtD
Rimonabant—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000997	CcSEcCtD
Rimonabant—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000996	CcSEcCtD
Rimonabant—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000206	0.000992	CcSEcCtD
Rimonabant—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00099	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000989	CcSEcCtD
Rimonabant—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000988	CcSEcCtD
Rimonabant—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000983	CcSEcCtD
Rimonabant—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000979	CcSEcCtD
Rimonabant—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.000974	CcSEcCtD
Rimonabant—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000202	0.000969	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0002	0.0065	CbGpPWpGaD
Rimonabant—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000958	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000952	CcSEcCtD
Rimonabant—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000951	CcSEcCtD
Rimonabant—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00095	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000197	0.00638	CbGpPWpGaD
Rimonabant—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000944	CcSEcCtD
Rimonabant—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000937	CcSEcCtD
Rimonabant—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.000937	CcSEcCtD
Rimonabant—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000937	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000195	0.00631	CbGpPWpGaD
Rimonabant—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000929	CcSEcCtD
Rimonabant—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000929	CcSEcCtD
Rimonabant—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000928	CcSEcCtD
Rimonabant—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.000923	CcSEcCtD
Rimonabant—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000916	CcSEcCtD
Rimonabant—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000914	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000908	CcSEcCtD
Rimonabant—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000907	CcSEcCtD
Rimonabant—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000906	CcSEcCtD
Rimonabant—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000905	CcSEcCtD
Rimonabant—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000902	CcSEcCtD
Rimonabant—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000889	CcSEcCtD
Rimonabant—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000886	CcSEcCtD
Rimonabant—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000876	CcSEcCtD
Rimonabant—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000875	CcSEcCtD
Rimonabant—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000872	CcSEcCtD
Rimonabant—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000871	CcSEcCtD
Rimonabant—Rash—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000864	CcSEcCtD
Rimonabant—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000863	CcSEcCtD
Rimonabant—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00086	CcSEcCtD
Rimonabant—Headache—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000858	CcSEcCtD
Rimonabant—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000856	CcSEcCtD
Rimonabant—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000847	CcSEcCtD
Rimonabant—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000831	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000171	0.00555	CbGpPWpGaD
Rimonabant—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000823	CcSEcCtD
Rimonabant—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000822	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000171	0.00553	CbGpPWpGaD
Rimonabant—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000819	CcSEcCtD
Rimonabant—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000816	CcSEcCtD
Rimonabant—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000815	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000169	0.00549	CbGpPWpGaD
Rimonabant—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000814	CcSEcCtD
Rimonabant—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000811	CcSEcCtD
Rimonabant—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00081	CcSEcCtD
Rimonabant—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000791	CcSEcCtD
Rimonabant—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000788	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000164	0.00531	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000164	0.00531	CbGpPWpGaD
Rimonabant—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000784	CcSEcCtD
Rimonabant—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000781	CcSEcCtD
Rimonabant—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00078	CcSEcCtD
Rimonabant—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00078	CcSEcCtD
Rimonabant—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000776	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00016	0.0052	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00016	0.0052	CbGpPWpGaD
Rimonabant—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000769	CcSEcCtD
Rimonabant—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000757	CcSEcCtD
Rimonabant—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000755	CcSEcCtD
Rimonabant—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000754	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000155	0.00502	CbGpPWpGaD
Rimonabant—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000744	CcSEcCtD
Rimonabant—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000736	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000153	0.00495	CbGpPWpGaD
Rimonabant—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000729	CcSEcCtD
Rimonabant—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000728	CcSEcCtD
Rimonabant—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000722	CcSEcCtD
Rimonabant—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000722	CcSEcCtD
Rimonabant—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00072	CcSEcCtD
Rimonabant—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000718	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000148	0.0048	CbGpPWpGaD
Rimonabant—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000701	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000146	0.00472	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000146	0.00472	CbGpPWpGaD
Rimonabant—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000695	CcSEcCtD
Rimonabant—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000695	CcSEcCtD
Rimonabant—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000694	CcSEcCtD
Rimonabant—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000691	CcSEcCtD
Rimonabant—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00068	CcSEcCtD
Rimonabant—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000669	CcSEcCtD
Rimonabant—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000663	CcSEcCtD
Rimonabant—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000663	CcSEcCtD
Rimonabant—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000659	CcSEcCtD
Rimonabant—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000655	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000134	0.00436	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000134	0.00434	CbGpPWpGaD
Rimonabant—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000625	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000129	0.00417	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000129	0.00417	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00408	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000126	0.00408	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000122	0.00396	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000122	0.00394	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00012	0.0039	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000116	0.00377	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000114	0.00371	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000114	0.00371	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000111	0.00359	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00011	0.00356	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000109	0.00354	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000101	0.00328	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.98e-05	0.00324	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.58e-05	0.0031	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.43e-05	0.00306	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.15e-05	0.00297	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.7e-05	0.00282	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.63e-05	0.0028	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.6e-05	0.00279	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.6e-05	0.00279	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.57e-05	0.00278	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.35e-05	0.00271	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.94e-05	0.00257	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.83e-05	0.00254	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.42e-05	0.0024	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.18e-05	0.00233	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.98e-05	0.00226	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.75e-05	0.00219	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.75e-05	0.00219	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.55e-05	0.00212	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.45e-05	0.00209	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.35e-05	0.00206	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.96e-05	0.00193	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.9e-05	0.00191	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.77e-05	0.00187	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.4e-05	0.00175	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.4e-05	0.00175	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.14e-05	0.00167	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.06e-05	0.00164	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.98e-05	0.00162	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.63e-05	0.0015	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.53e-05	0.00147	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.69e-05	0.00119	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	3.65e-05	0.00118	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.41e-05	0.0011	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.39e-05	0.0011	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.13e-05	0.00102	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.12e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	3.11e-05	0.00101	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000867	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.66e-05	0.000862	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.66e-05	0.000861	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.41e-05	0.000781	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.05e-05	0.000664	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2e-05	0.000649	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000509	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.43e-05	0.000464	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000396	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.43e-06	0.000208	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	6.37e-06	0.000207	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.45e-06	0.000177	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.2e-06	0.000136	CbGpPWpGaD
